Coverage for ultrasound diagnostic
This article was originally published in The Gray Sheet
Executive Summary
CMS 1proposes Feb. 26 to remove national non-coverage of cardiac output Doppler monitoring, noting "there is sufficient evidence to conclude that esophageal Doppler monitoring of cardiac output for ventilated patients in the ICU and operative patients with a need for intra-operative fluid optimization is reasonable and necessary." CMS was asked to reconsider its existing non-coverage policy by UK-based Deltex Medical Group, whose CardioQ esophageal Doppler monitor was cleared by FDA in 2003 (2"The Gray Sheet" Sept. 11, 2006, p. 12). Comments on the proposal are due March 28, with a final decision expected in May...
You may also be interested in...
CardioQ covered
UK firm Deltex Medical's CardioQ esophageal Doppler monitor gets national coverage from CMS May 22. The agency's 1decision to cover Doppler monitoring of cardiac output for ventilated patients in the ICU and patients with a need for intra-operative fluid optimization during surgery mirrors CMS' earlier proposal to reverse its long-standing noncoverage policy for the procedure (2"The Gray Sheet" March 5, 2007, In Brief). The esophageal Doppler monitor competes with pulmonary artery catheters, providing real-time data on left ventricular blood flow. "Given the breadth of the coverage determination, between 5 and 10 million patients [in the U.S.] annually would benefit ... using CardioQ," Deltex CEO Andy Hill told "The Gray Sheet"...
CMS Reconsiders Medicare Coverage For Esophageal Blood Flow Monitor
CMS is reconsidering Medicare coverage for a probe that uses the Doppler effect to measure the volume of blood being pumped through the body in sedated patients
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.